TLR4 and Sepsis: This new delivery protocol has considerable therapeutic potential as shown in our model of sepsis-induced acute lung injury induced by intratracheal lipopolysaccharide (LPS) injection in C3H/HeN (TLR4+/+) and C3H/HeJ (TLR4–/–) mice.